BCG vaccination against tuberculosis in European badgers (Meles meles): a review

Comparative Immunology, Microbiology and Infectious Diseases
Philip A RobinsonDarrell A Abernethy

Abstract

Tuberculosis (TB) is a significant animal health problem in many parts of the world, and reservoirs of infection in wild animals complicate disease control efforts in farmed livestock, particularly cattle. Badgers (Meles meles) are a significant wildlife reservoir of Mycobacterium bovis infection for cattle in the United Kingdom (UK) and Republic of Ireland (ROI). Vaccination of badgers using an M. bovis strain bacille Calmette-Guérin (BCG) vaccine could potentially be an option in the national TB eradication strategy. Wildlife vaccination has been used successfully for other diseases in wildlife species, and may have a role to play in reducing M. bovis transmission at the wildlife-livestock interface. Research to date has provided evidence that BCG is protective in badgers, and a parenteral badger BCG vaccine has been licensed in the UK. Further research is required to develop effective strategies for vaccine deployment and to determine the effect of badger vaccination on cattle TB incidence.

References

Sep 12, 1985·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R M Anderson, W Trewhella
Nov 4, 1985·Nature·R M Anderson, R M May
Jan 1, 1995·Research in Veterinary Science·F E AldwellB M Buddle
May 1, 1994·Veterinary Microbiology·J P Caffrey
May 1, 1994·Veterinary Microbiology·S D NeillJ Hanna
Jan 1, 1996·Annual Review of Immunology·R M ZinkernagelH Hengartner
Jul 13, 1996·The Veterinary Record·K Stöhr, F M Meslin
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·M E WoolhouseR M Anderson
Sep 14, 2000·The Veterinary Record·P C White, S J Whiting
Dec 22, 2000·Research in Veterinary Science·J Gallagher, R S Clifton-Hadley
Jul 21, 2001·Tuberculosis·G C Smith
Jul 21, 2001·Tuberculosis·J M PollockS D Neill
Mar 21, 2002·The Lancet Infectious Diseases·Marcel A Behr
Dec 25, 2002·Emerging Infectious Diseases·Daniel T HaydonM Karen Laurenson
May 6, 2004·JAMA : the Journal of the American Medical Association·Naomi E AronsonLee H Harrison
Dec 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jean I TsaoAlan G Barbour
Mar 8, 2005·Preventive Veterinary Medicine·J M GriffinS J More
Dec 1, 1995·New Zealand Veterinary Journal·F E AldwellB M Buddle
Dec 6, 2005·Veterinary Microbiology·D A AbernethyA R Roberts
Dec 6, 2005·Veterinary Microbiology·B M BuddleM Denis
Dec 31, 2005·Veterinary Microbiology·J M PollockJ McNair
Jan 4, 2006·Veterinary Microbiology·F J Reviriego Gordejo, J P Vermeersch
May 12, 2006·Veterinary Immunology and Immunopathology·S LesellierM A Chambers
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rosie WoodroffeW Ivan Morrison
Nov 23, 2006·The Veterinary Journal·M L CrossF E Aldwell
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roland BroschStewart T Cole
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hans-Willi MittrückerStefan H E Kaufmann
Sep 4, 2007·Comparative Immunology, Microbiology and Infectious Diseases·Jayne C Hope, Bernardo Villarreal-Ramos
Nov 21, 2007·Veterinary Microbiology·Victoria NaranjoJosé de la Fuente
Jan 29, 2008·BMC Infectious Diseases·Rosemary E WeirHazel M Dockrell

❮ Previous
Next ❯

Citations

Apr 11, 2013·Epidemiology and Infection·J L HardstaffP C L White
Aug 9, 2013·Proceedings. Biological Sciences·H Charles J GodfrayAngela R McLean
Jun 16, 2012·Veterinary Immunology and Immunopathology·Ramon A Juste
Mar 1, 2015·Veterinary Microbiology·Simon J More, Margaret Good
Jan 1, 2014·Frontiers in Veterinary Science·Christian GortazarMariana Boadella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.